John G Ullman & Associates Inc. Has $231,000 Stock Holdings in iShares Biotechnology ETF (NASDAQ:IBB)
John G Ullman & Associates Inc. decreased its holdings in iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 38.2% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,700 shares of the financial services provider’s stock after selling 1,050 shares during the quarter. […]